Ecovyst Inc.(ECVT)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Ecovyst Inc. (ECVT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ECVT at 48.7/100 on a 32-signal composite quality model, placing it at rank #1,708 of 2,961 stocks — the bottom half of the AI-ranked universe. ECVT scores in the top quartile across earnings quality (86.2). Areas of concern include institutional flow (13.3) and profitability (23.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 48.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Ecovyst Inc. reports quarterly revenue of $250.0M, net income of $7.9M, an operating margin of 7.8%. Top institutional holders of ECVT by reported 13-F value include BlackRock, Rubric Capital Management, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. ECVT trades on the NYSE exchange and files with the SEC under CIK 1708035. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ECVT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Ecovyst Inc. directly from SEC EDGAR.